BMY
Bristol-Myers SquibbยทNYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BMY Profile
Bristol-Myers Squibb Company
A global biopharmaceutical company that develops and commercializes innovative medicines for serious diseases
Route 206 & Province Line Road, Princeton, New Jersey 08543
Biopharmaceuticals and Sales
Bristol-Myers Squibb Company was incorporated under the laws of Delaware in August 1933 as Bristol-Myers Corporation, inheriting a business founded in New York in 1887. In 1989, due to the merger, the company changed its name to Bristol-Myers Squibb Company. The company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global scale. The company expects the acquisition of Celgene and MyoKardia to further position the company as a leading biopharmaceutical company, expanding its portfolio in oncology, hematology, immunology and cardiovascular with several recent assets and additional external partnerships.
